[Complementary therapy in NSCLC. Supportive treatment in thoracic oncology. Management of chemotherapy induced anaemia and neutropenia, nausea and vomiting and bone metastases].
The aim of supportive treatment is to minimise the toxic effects of antineoplastic therapy. More useful new drugs are now available for the management of chemotherapy induced anaemia, neutropenia, and nausea and vomiting. One can include the treatment of bone metastases with biphosphonates. Recommendations on the use of these treatments have been made by various specialist organisations. This article reviews the recent data concerning these developments in thoracic oncology.
Bréchot
J-M
JM
Service d'Oncologie Médicale, Hôpital Avicenne, Bobigny, France. jeanne-marie.brechot@avc.ap-hop-paris.fr
D000740:Anemia / Q000139:chemically induced* / Q000628:therapy*; D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000529:Complementary Therapies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced* / Q000628:therapy*; D009503:Neutropenia / Q000139:chemically induced* / Q000628:therapy*; D014839:Vomiting / Q000139:chemically induced* / Q000628:therapy*